Serum amyloid P component binding to shiga toxin 2 requires both A subunit and B pentamer

Infection and Immunity

Volumn 71, Issue 10, 2003, Pages 6075-6078

  Marcato, Paola ^a   Vander Helm, Kathleen ^a   Mulvey, George L ^a   Armstrong, Glen D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DAISY PROTEIN; POLYVALENT GLOBOTRIAOSYLCERAMIDE RECEPTOR ANALOG; PROTEIN; SERUM AMYLOID A; SHIGA TOXIN; UNCLASSIFIED DRUG; VEROTOXIN 2;

APOPTOSIS; ARTICLE; BINDING AFFINITY; COMPETITIVE INHIBITION; CYTOTOXICITY; ESCHERICHIA COLI; LIGAND BINDING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN;

BINDING SITES; BINDING, COMPETITIVE; CELL LINE; HUMANS; LIGANDS; NEUTRALIZATION TESTS; OLIGOSACCHARIDES; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; SERUM AMYLOID P-COMPONENT; SHIGA-LIKE TOXIN I; SHIGA-LIKE TOXIN II;

EID: 0141557580     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.10.6075-6078.2003     Document Type: Article

References (17)

1. Armstrong, G. D., E. Fodor, and R. Vanmaele. 1991. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences. J. Infect. Dis. 164:1160-1167.
2. Hashimoto, H., K. Mizukoshi, M. Nishi, T. Kawakita, S. Hasui, Y. Kato, Y. Ueno, R. Takeya, N. Okuda, and T. Takeda. 1999. Epidemic of gastrointestinal tract infection including hemorrhagic colitis attributable to Shiga toxin 1-producing Escherichia coli O118:H2 at a junior high school in Japan. Pediatrics 103:E2. [Online.]
3. Head, S. C., M. A. Karmali, and C. A. Lingwood. 1991. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J. Biol. Chem. 266:3617-3621.
4. Kimura, T., S. Tani, Y. Matsumoto Yi, and T. Takeda. 2001. Serum amyloid P component is the Shiga toxin 2-neutralizing factor in human blood. J. Biol. Chem. 276:41576-41579.
5. Kimura, T., S. Tani, M. Motoki, and Y. Matsumoto. 2003. Role of Shiga toxin 2 (Stx2)-binding protein, human serum amyloid P component (HuSAP), in Shiga toxin-producing Escherichia coli infections: assumption from in vitro and in vivo study using HuSAP and anti-Stx2 humanized monoclonal antibody TMA-15. Biochem. Biophys. Res. Commun. 305:1057-1060.
6. Kleanthous, H., H. R. Smith, S. M. Scotland, R. J. Gross, B. Rowe, C. M. Taylor, and D. V. Milford. 1990. Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2. Microbiological aspects. Arch. Dis. Child. 65:722-727.
7. Louise, C. B., and T. G. Obrig. 1995. Specific interaction of Escherichia coli O157:HT-derived Shiga-like toxin II with human renal endothelial cells. J. Infect. Dis. 172:1397-1401.
8. Marcato, P., G. Mulvey, and G. D. Armstrong. 2002. Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells. Infect. Immun. 70:1279-1286.
9. Marcato, P., G. Mulvey, R. J. Read, K. Vander Helm, P. N. Nation, and G. D. Armstrong. 2001. Immunoprophylactic potential of cloned Shiga toxin 2 B subunit. J. Infect. Dis. 183:435-443.
10. Mulvey, G., R. Vanmaele, M. Mrazek, M. Cahill, and G. D. Armstrong. 1998. Affinity purification of Shiga-toxin I and Shiga-like toxin II. J. Microbiol. Methods 32:247-252.
11. Mulvey, G. L., P. Marcato, P. I. Kitov, J. Sadowska, D. R. Bundle, and G. D. Armstrong. 2003. Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands. J. Infect. Dis. 187:640-649.
12. Nelson, S. R., G. A. Tennent, D. Sethi, P. E. Gower, F. W. Ballardie, S. Amatayakul-Chantler, and M. B. Pepys. 1991. Serum amyloid P component in chronic renal failure and dialysis. Clin. Chim. Acta 200:191-199.
13. Ostroff, S. M., P. I. Tarr, M. A. Neill, J. H. Lewis, N. Hargrett-Bean, and J. M. Kobayashi. 1989. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J. Infect. Dis. 160:994-998.
14. Rutjes, N. W., B. A. Binnington, C. R. Smith, M. D. Maloney, and C. A. Lingwood. 2002. Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model. Kidney Int. 62:832-845.
15. Suzuki, A., H. Doi, F. Matsuzawa, S. Aikawa, K. Takiguchi, H. Kawano, M. Hayashida, and S. Ohno. 2000. Bcl-2 antiapoptotic protein mediates verotoxin II-induced cell death: possible association between Bcl-2 and tissue failure by E. coli O157:H7. Genes Dev. 14:1734-1740.
16. Thorpe, C. M., W. E. Smith, B. P. Hurley, and D. W. Acheson. 2001. Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infect. Immun. 69:6140-6147.
17. Yamasaki, C., Y. Natori, X. T. Zeng, M. Ohmura, S. Yamasaki, and Y. Takeda. 1999. Induction of cytokines in a human colon epithelial cell line by Shiga toxin 1 (Stx1) and Stx2 but not by non-toxic mutant Stx1 which lacks N-glycosidase activity. FEBS Lett. 442:231-234.